Pharmaceutical GLP-1 receptor agonists elevate circulating GLP-1 activity to approximately 3,000% of baseline levels

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

The systematic study of the natural world through observation, experiment, and theory.